These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18182814)

  • 1. Etoricoxib-induced erythema-multiforme-like eruption.
    Thirion L; Nikkels AF; Piérard GE
    Dermatology; 2008; 216(3):227-8. PubMed ID: 18182814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fixed drug eruption and generalised erythema following etoricoxib.
    Augustine M; Sharma P; Stephen J; Jayaseelan E
    Indian J Dermatol Venereol Leprol; 2006; 72(4):307-9. PubMed ID: 16880582
    [No Abstract]   [Full Text] [Related]  

  • 3. Etoricoxib-induced acute generalized exanthematous pustulosis.
    Mäkelä L; Lammintausta K
    Acta Derm Venereol; 2008; 88(2):200-1. PubMed ID: 18311467
    [No Abstract]   [Full Text] [Related]  

  • 4. Fixed drug eruption caused by etoricoxib with tolerance to celecoxib and parecoxib.
    Ponce V; Muñoz-Bellido F; Moreno E; Laffond E; González A; Dávila I
    Contact Dermatitis; 2012 Feb; 66(2):107-8. PubMed ID: 22233472
    [No Abstract]   [Full Text] [Related]  

  • 5. Fixed drug eruption caused by etoricoxib--2 cases confirmed by patch testing.
    Andrade P; Gonçalo M
    Contact Dermatitis; 2011 Feb; 64(2):118-20. PubMed ID: 21210830
    [No Abstract]   [Full Text] [Related]  

  • 6. Fixed drug eruption by etoricoxib confirmed by patch test.
    Sousa AS; Cardoso JC; Gouveia MP; Gameiro AR; Teixeira VB; Gonçalo M
    An Bras Dermatol; 2016; 91(5):652-654. PubMed ID: 27828643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etoricoxib-induced fixed drug eruption with positive lesional patch tests.
    Calistru AM; Cunha AP; Nogueira A; Azevedo F
    Cutan Ocul Toxicol; 2011 Jun; 30(2):154-6. PubMed ID: 21108578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serious skin reactions and selective COX-2 inhibitors: a case series from prescription-event monitoring in England.
    Layton D; Marshall V; Boshier A; Friedmann P; Shakir SA
    Drug Saf; 2006; 29(8):687-96. PubMed ID: 16872242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fixed drug eruption due to etoricoxib in a patient with tolerance to celecoxib: the value of patch testing.
    Gómez de la Fuente E; Pampín Franco A; Caro Gutiérrez D; López Estebaranz JL
    Actas Dermosifiliogr; 2014 Apr; 105(3):314-5. PubMed ID: 24661957
    [No Abstract]   [Full Text] [Related]  

  • 10. Fixed drug eruption secondary to etoricoxib.
    Rawlings N; Joshi S; Sandison A; Carey B
    Br J Oral Maxillofac Surg; 2024 Jul; 62(6):571-574. PubMed ID: 38816329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COX-2 inhibitors in patients with sensitivity to nonselective NSAIDs.
    Cimbollek S; Quiralte J; Avila R
    N Engl J Med; 2009 Nov; 361(22):2197-8. PubMed ID: 19940308
    [No Abstract]   [Full Text] [Related]  

  • 12. Erythema multiforme-like drug reaction to sorafenib.
    Lewin J; Farley-Loftus R; Pomeranz MK
    J Drugs Dermatol; 2011 Dec; 10(12):1462-3. PubMed ID: 22134572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celecoxib-induced erythema multiforme-type drug eruption with a positive patch test.
    Arakawa Y; Nakai N; Katoh N
    J Dermatol; 2011 Dec; 38(12):1185-8. PubMed ID: 22103805
    [No Abstract]   [Full Text] [Related]  

  • 14. Erythema multiforme-like eruption in association with severe headache following pyritinol.
    Nachbar F; Korting HC; Vogl T
    Dermatology; 1993; 187(1):42-6. PubMed ID: 8324277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case report on toxic epidermal necrolysis with etoricoxib.
    Kameshwari JS; Devde R
    Indian J Pharmacol; 2015; 47(2):221-3. PubMed ID: 25878388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.
    Laine L; Curtis SP; Cryer B; Kaur A; Cannon CP;
    Lancet; 2007 Feb; 369(9560):465-73. PubMed ID: 17292766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case of Erythema Multiforme Drug Eruption Induced by Ledipasvir/Sofosbuvir.
    Wang Y; Zheng S
    Am J Ther; 2018; 25(5):e586-e587. PubMed ID: 30188425
    [No Abstract]   [Full Text] [Related]  

  • 18. Piroxicam-induced erythema multiforme.
    Prieto A; De Barrio M; Pérez C; Velloso A; Baeza ML; Herrero T
    Contact Dermatitis; 2004 Apr; 50(4):263. PubMed ID: 15186396
    [No Abstract]   [Full Text] [Related]  

  • 19. Bullous fixed drug eruption to etoricoxib--further evidence of intraepidermal CD8+ T cell involvement.
    Duarte AF; Correia O; Azevedo R; do Carmo Palmares M; Delgado L
    Eur J Dermatol; 2010; 20(2):236-8. PubMed ID: 20110201
    [No Abstract]   [Full Text] [Related]  

  • 20. Depot sulfonamid associated linear IgA bullous dermatosis with erythema multiforme-like clinical features.
    Tonev S; Vasileva S; Kadurina M
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):165-8. PubMed ID: 9784046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.